TB-500 is a synthetic research compound (a fragment of thymosin β-4) supplied as a sterile lyophilized powder for in-vitro and laboratory research applications. Each vial contains 10 mg of compound, independently confirmed by third-party analytical testing and backed by a Certificate of Analysis.
Specifications
- Compound: TB-500
- Classification: Synthetic research compound
- Format: Lyophilized powder
- Quantity: 10 mg per vial
- Purity: Batch-specific — see Certificate of Analysis
- Appearance: White lyophilized powder
- CAS Number: Available on COA
Storage & Handling
Store sealed vials in a cool, dry place away from light and moisture. For short-term storage, keep at or below 8°C; for long-term storage, keep at -20°C. After reconstitution, store at 2–8°C. Handle in accordance with standard laboratory practice for research compounds.
Certificates of Analysis
Every batch of TB-500 is independently tested by a third-party lab before release. All published batches for this product:
Peptide Purity 99.466% · Net Content 12.56mg · Identity Confirmed
Kovera Labs · COA #KVR-2026-AA25AA · Issued 08/08/2026
Verify: koveralabs.com/verify · Access Code: N9V0YTS
Includes
1 × TB-500 10 mg lyophilized vial





